All In Biotech

Drug Trial Radar · NCT07652658

A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

A Phase IIb Study to Evaluate the Efficacy, Safety, and Tolerability of AZD8965 in Participants With Idiopathic Pulmonary Fibrosis (IPF) (ARGiNAUT)

Last checked: Nov 19, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 359 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

359

Planned (sponsor's estimate)

Start

Jun 11, 2026

Primary completion

Sep 18, 2028

Study completion Sep 18, 2028

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Jun 17, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase IIb study aims to evaluate the efficacy, safety, and tolerability of 3 doses of AZD8965 treatment compared to placebo in participants with IPF, including those on antifibrotic therapy (nintedanib, pirfenidone, nerandomilast), either alone or in combination, or in those not on antifibrotic therapy.

Conditions

  • Idiopathic Pulmonary Fibrosis (IPF)

Interventions

  • Placebo for AZD8965Other

    Placebo for AZD8965

  • AZD8965 low doseDrug

    AZD8965 low dose

  • AZD8965 medium doseDrug

    AZD8965 medium dose

  • AZD8965 high doseDrug

    AZD8965 high dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate the clinical efficacy of AZD8965 compared with placebo on the absolute change from baseline in FVC in mL at Week 24Time frame: at Week 24

Locations

198 sites in 23 countries. Site status is shown where the registry gives one.

  • Research Site

    Birmingham, Alabama · Not yet recruiting

  • Research Site

    Phoenix, Arizona · Not yet recruiting

  • Research Site

    Phoenix, Arizona · Recruiting

  • Research Site

    Loma Linda, California · Not yet recruiting

  • Research Site

    Los Angeles, California · Not yet recruiting

  • Research Site

    Newport Beach, California · Recruiting

  • Research Site

    Sacramento, California · Not yet recruiting

  • Research Site

    Stanford, California · Not yet recruiting

  • Research Site

    Aurora, Colorado · Not yet recruiting

  • Research Site

    Denver, Colorado · Recruiting

  • Research Site

    Ocala, Florida · Withdrawn

  • Research Site

    Weston, Florida · Not yet recruiting

  • Research Site

    Atlanta, Georgia · Recruiting

  • Research Site

    Boise, Idaho · Recruiting

  • Research Site

    Champaign, Illinois · Recruiting

  • Research Site

    Chicago, Illinois · Not yet recruiting

  • Research Site

    Kansas City, Kansas · Not yet recruiting

  • Research Site

    Lexington, Kentucky · Not yet recruiting

  • Research Site

    Baltimore, Maryland · Not yet recruiting

  • Research Site

    Boston, Massachusetts · Not yet recruiting

  • Research Site

    Ann Arbor, Michigan · Not yet recruiting

  • Research Site

    Detroit, Michigan · Not yet recruiting

  • Research Site

    New York, New York · Not yet recruiting

  • Research Site

    New York, New York · Recruiting

  • Research Site

    Greensboro, North Carolina · Not yet recruiting

  • Research Site

    Cincinnati, Ohio · Not yet recruiting

  • Research Site

    Oklahoma City, Oklahoma · Not yet recruiting

  • Research Site

    Fountain Hill, Pennsylvania · Recruiting

  • Research Site

    Philadelphia, Pennsylvania · Not yet recruiting

  • Research Site

    Philadelphia, Pennsylvania · Recruiting

  • Research Site

    Charleston, South Carolina · Not yet recruiting

  • Research Site

    Dallas, Texas · Not yet recruiting

  • Research Site

    El Paso, Texas · Recruiting

  • Research Site

    Houston, Texas · Not yet recruiting

  • Research Site

    Burlington, Vermont · Not yet recruiting

  • Research Site

    Richmond, Virginia · Not yet recruiting

  • Research Site

    Alberdi, Argentina · Not yet recruiting

  • Research Site

    Buenos Aires, Argentina · Not yet recruiting

  • Research Site

    Ciudad de Buenos Aires, Argentina · Not yet recruiting

  • Research Site

    Florida, Argentina · Not yet recruiting

Showing 40 of 198 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.